2m 2m 2m 2m 2m 2m 2m
MAPLIGHT THERAPE (MPLT)
NASDAQ
$8.24+$0.07 (+0.92%)
Price as of Oct 22, 2026 5:25 PM EDT- $431.2MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
MAPLIGHT THERAPE (MPLT)
$8.24+$0.07 (+0.92%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
NOVO HOLDINGS A/S | 8.65% | 3.7M | 0 (0.00%) | Jun 30, 2026 |
FCPM III SERVICES B.V. | 7.57% | 3.2M | 0 (0.00%) | Jun 30, 2026 |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 6.53% | 2.8M | -20,209 (-0.73%) | Jun 30, 2026 |
GOLDMAN SACHS GROUP INC | 4.57% | 1.9M | -46,561 (-2.39%) | Jun 30, 2026 |
PRICE T ROWE ASSOCIATES INC /MD/ | 3.34% | 1.4M | +1.3M (+92.08%) | Jun 30, 2026 |
BLACKROCK, INC. | 2.41% | 1.0M | -314,597 (-30.69%) | Jun 30, 2026 |
NAN FUNG GROUP HOLDINGS LTD | 2.28% | 971,253 | 0 (0.00%) | Jun 30, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 1.80% | 768,591 | +64,554 (+8.40%) | Jun 30, 2026 |
T. Rowe Price Small-Cap Stock Fund, Inc. | 1.47% | 625,046 | -678 (-0.11%) | Jun 30, 2026 |
T. Rowe Price Small-Cap Value Fund, Inc. | 1.42% | 605,601 | -15,727 (-2.60%) | Jun 30, 2026 |
T. Rowe Price Quantitative Management Funds, Inc. | 1.02% | 435,396 | +435,396 (+100.00%) | Jun 30, 2026 |
FIDELITY CAPITAL TRUST | 0.95% | 406,402 | +406,402 (+100.00%) | Jul 31, 2026 |
SMALLCAP WORLD FUND INC | 0.95% | 404,389 | +404,389 (+100.00%) | Jun 30, 2026 |
T. Rowe Price New Horizons Fund, Inc. | 0.94% | 398,809 | +351,906 (+88.24%) | Jun 30, 2026 |
Current Ownership Distribution
- Institutions74.2M (81.33%)
- Mutual Funds14.9M (16.33%)
- Insiders2.1M (2.34%)
- Other0 (0.00%)
Insider Transactions
- 2.34% (2.1M)Current InsiderOwnership (%, shares)
- 5Number of InsiderBuying (last 12 months)
- $1.5BAmount of InsiderBuying (last 12 months)
- 7Number of InsiderSelling (last 12 months)
- $351.1MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Hanson Kristopher General Counsel | Sell | Oct 15, 2026 | $72,881.60 | 9,020 | $8.08 | 128,024 |
Foff Erin Pennock Chief Medical Officer | Sell | Oct 15, 2026 | $124,068.40 | 15,355 | $8.08 | 296,906 |
Kroeger Christopher A. Chief Executive Officer | Sell | Oct 15, 2026 | $595,423.28 | 73,691 | $8.08 | 1.2M |
Kreitzer Anatol Chief Discovery Officer | Sell | Oct 15, 2026 | $96,024.32 | 12,248 | $7.84 | 168,678 |
GILLIS JONATHAN CAO and Interim CFO | Sell | Oct 15, 2026 | $82,149.36 | 10,167 | $8.08 | 142,315 |
Hanson Kristopher General Counsel | Sell | Sep 16, 2026 | $192,660.03 | 16,509 | $11.67 | 137,044 |
Kreitzer Anatol Chief Discovery Officer | Award | Aug 17, 2026 | $0.00 | 24,455 | $0.00 | 24,455 |
Hanson Kristopher General Counsel | Award | Aug 17, 2026 | $0.00 | 31,395 | $0.00 | 31,395 |
Lillie James Woodruff Chief Scientific Officer | Award | Aug 17, 2026 | $0.00 | 31,395 | $0.00 | 31,395 |
GILLIS JONATHAN CAO and Interim CFO | Award | Aug 17, 2026 | $0.00 | 24,455 | $0.00 | 24,455 |
Foff Erin Pennock Chief Medical Officer | Award | Aug 17, 2026 | $0.00 | 54,240 | $0.00 | 54,240 |
Hanson Kristopher General Counsel | Award | Aug 17, 2026 | $0.00 | 7,730 | $0.00 | 153,553 |
Lillie James Woodruff Chief Scientific Officer | Award | Aug 17, 2026 | $0.00 | 7,730 | $0.00 | 210,110 |
Kroeger Christopher A. Chief Executive Officer | Award | Aug 17, 2026 | $0.00 | 93,955 | $0.00 | 93,955 |
Kreitzer Anatol Chief Discovery Officer | Award | Aug 17, 2026 | $0.00 | 6,020 | $0.00 | 180,926 |
GILLIS JONATHAN CAO and Interim CFO | Award | Aug 17, 2026 | $0.00 | 2,813 | $0.00 | 2,813 |
Foff Erin Pennock Chief Medical Officer | Award | Aug 17, 2026 | $0.00 | 13,360 | $0.00 | 312,261 |
Kroeger Christopher A. Chief Executive Officer | Award | Aug 17, 2026 | $0.00 | 23,145 | $0.00 | 1.3M |
GILLIS JONATHAN CAO and Interim CFO | Award | Aug 17, 2026 | $0.00 | 6,020 | $0.00 | 150,260 |
GILLIS JONATHAN CAO and Interim CFO | Award | Aug 17, 2026 | $0.00 | 2,222 | $0.00 | 152,482 |
Catalyst4, Inc. | Buy | Aug 14, 2026 | $33.3M | 2.9M | $11.38 | 2.9M |
Catalyst4, Inc. | Buy | Aug 14, 2026 | $50.1M | 4.4M | $11.38 | 25.3M |
Lillie James Woodruff Chief Scientific Officer | Sell | Aug 03, 2026 | $276,908.28 | 22,082 | $12.54 | 202,380 |
Catalyst4, Inc. | Buy | Jul 30, 2026 | $13.0M | 1.0M | $13.00 | 20.9M |
Catalyst4, Inc. | Buy | Jul 29, 2026 | $37,890.00 | 3,000 | $12.63 | 19.9M |
Cox Troy | Buy | Jul 28, 2026 | $148,702.40 | 15,620 | $9.52 | 15,620 |
Catalyst4, Inc. | Buy | Jul 28, 2026 | $1.5M | 141,088 | $10.74 | 19.8M |
Catalyst4, Inc. | Buy | Jul 28, 2026 | $761,392.91 | 65,137 | $11.69 | 19.9M |
Kreitzer Anatol Chief Discovery Officer | Sell | Jul 17, 2026 | $104,962.65 | 2,833 | $37.05 | 189,246 |
Foff Erin Pennock Chief Medical Officer | Sell | Jul 17, 2026 | $138,562.40 | 3,656 | $37.90 | 298,901 |